NICE has recommended dupilumab for adults with uncontrolled COPD and raised eosinophils, citing fewer exacerbations and ...
A biologic injection that reduces chronic obstructive pulmonary disease (COPD) flare-ups by around a third has been approved for use on the NHS in England and Wales. The National Institute for Health ...
NICE has estimated that around 40% of people with COPD have elevated blood levels of eosinophils and, if half the eligible ...
China NMPA approves GSK’s Trelegy Ellipta for use in adults with uncontrolled asthma: London, UK Saturday, January 24, 2026, 09:00 Hrs [IST] GSK plc announced that China’s Nat ...
GSK has secured approval in China for Trelegy Ellipta as a maintenance treatment for adults with asthma, adding to its existing indication in COPD and making it the only single inhaler triple therapy ...
Updated initial conversion table based on clinical trials in adults showing significantly improved mealtime glycemic ...
Frontline: Surgery to remove the tumor is often considered, sometimes followed by chemotherapy or radiation to reduce ...
The corticosteroids market is driven by rising chronic diseases like asthma and COPD and innovations in drug delivery systems, enhancing treatment adherence. However, prolonged usage safety concerns ...
The Central Drugs Standard Control Organisation (CDSCO) has granted multiple CT-18 approvals between January 2020 and ...
Population aging is reshaping the landscape of respiratory disease, with COPD, idiopathic pulmonary fibrosis, bronchiectasis, ...
Allergic diseases represent a major global health burden, placing significant strain on health care systems worldwide. Severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results